Neutrophil-to-HDL Ratio (NHR), Explained

What the NHR brings together in one number

The neutrophil-to-HDL cholesterol ratio (NHR) is a single value derived from two routine measurements — absolute neutrophil count from a CBC and HDL cholesterol from a lipid panel. It quantifies the balance between inflammatory drive (neutrophils) and anti-inflammatory, lipid-clearing capacity (HDL), capturing how the immune and lipid systems interact in ways that neither marker reveals alone.

High neutrophils plus low HDL produces a high NHR — a signal that the body may be in an inflammatory, stress-reactive state. Low neutrophils and robust HDL produce a low NHR, suggesting better systemic balance. Because both inputs come from standard bloodwork, the ratio adds interpretive depth at no additional testing cost.

Why neutrophils and HDL are interpreted as a pair

Neither neutrophil count nor HDL cholesterol alone captures the vascular-immune interaction that underlies cardiometabolic risk. Neutrophils are the innate immune system's first responders — fast, aggressive, and capable of releasing neutrophil extracellular traps (NETs) that damage endothelial tissue when chronically activated. HDL particles, by contrast, perform anti-inflammatory and reverse-cholesterol-transport functions that help resolve the oxidative damage neutrophils can leave behind.

When lifestyle stress, poor diet, or chronic inflammation persist, neutrophils multiply and HDL declines. This imbalance drives oxidative stress, damages blood vessel linings, and accelerates plaque buildup. Studying each marker in isolation misses this interplay: a neutrophil count of 5.0 ×10³/µL reads differently when HDL is 65 mg/dL versus 32 mg/dL. The ratio makes that contrast explicit, which is why researchers have examined NHR as a dual-system signal of vascular inflammation and metabolic strain.

How the NHR is calculated from two inputs

NHR: Absolute Neutrophil Count (×10³/µL or cells/µL) ÷ HDL Cholesterol (mg/dL)

Units are not standardized across laboratories. Because different labs may report neutrophil count in cells/µL rather than ×10³/µL, and HDL in mmol/L rather than mg/dL, it is important to use the same lab and the same unit system across all retests to ensure values are comparable over time.

There is also an asymmetry in fasting requirements: neutrophil count does not require fasting, but HDL cholesterol is ideally drawn from a fasting sample. When possible, collect both from the same fasting blood draw to reduce variability.

Worked example

• Lower-risk pattern: Neutrophil count 4.5 ×10³/µL ÷ HDL 50 mg/dL = NHR 0.09
• Higher-risk pattern: Neutrophil count 6.5 ×10³/µL ÷ HDL 38 mg/dL = NHR 0.17 — a pattern associated in research with elevated cardiometabolic risk

The contrast illustrates how the ratio can shift meaningfully even when neither individual value appears dramatically abnormal in isolation.

Where your NHR sits on the risk continuum

There is no universal reference range for NHR because the result depends on how a given laboratory reports neutrophil count and HDL units. Conceptually, lower is better — provided neutrophil count remains within a healthy immune range. Studies have found that individuals with higher NHR values tend to show greater risk for hypertension, atherosclerosis, insulin resistance, and fatty liver disease.

• Elevated NHR typically signals an inflammatory tilt: neutrophil counts rising, HDL falling, or both. This pattern is common during infection, after acute stress, or in chronic inflammatory states such as obesity, metabolic syndrome, and cardiovascular disease. Persistent elevation may point toward endothelial stress and oxidative burden. A temporary rise during infection or after intense exercise is adaptive — what matters is whether the value returns to baseline.
• Low NHR often reflects stable immune function and adequate anti-inflammatory defense. However, very low neutrophil counts — as seen with certain medications, viral infections, or bone marrow suppression — can also depress the ratio independently of HDL. If HDL is extremely high (as in genetic hyperalphalipoproteinemia), the ratio can appear artificially low. Trends across multiple stable draws offer clearer insight than any single value.

Mechanisms that push the NHR higher

Neutrophil activation pathways. Obesity, metabolic syndrome, smoking, and sleep deprivation each upregulate NF-κB signaling, a master inflammatory transcription factor that promotes neutrophil production and prolongs neutrophil lifespan. Chronic NF-κB activation is mechanistically linked to increased NET formation — a process in which neutrophils release webs of DNA and enzymes that amplify vascular inflammation and raise the numerator of the NHR. Research shows that visceral adiposity in particular is associated with sustained neutrophil priming, meaning these cells remain in a hair-trigger state even in the absence of active infection.

HDL synthesis and anti-inflammatory remodeling. Sedentary behavior and diets high in refined carbohydrates are associated with suppressed apolipoprotein A-I (apoA-I) production — the structural protein that anchors HDL particles. Reduced apoA-I synthesis lowers HDL particle number and impairs the anti-inflammatory remodeling function of HDL, reducing the denominator of the NHR. Research also shows that HDL particles in metabolically stressed individuals undergo oxidative modification that renders them dysfunctional even when HDL-C concentration appears adequate, compounding the denominator effect.

Cortisol and catecholamine pathway. Psychological stress and sleep disruption elevate cortisol and catecholamines, which simultaneously mobilize neutrophils from bone marrow reserves — raising the numerator — and suppress hepatic apoA-I synthesis — lowering the denominator. This dual action means that chronic stress is mechanistically linked to NHR elevation through two independent routes, which may explain why psychological and physiological stressors show consistent associations with cardiometabolic risk markers in population research.

Inflammatory and lipid markers that frame the NHR

• Neutrophil-to-lymphocyte ratio (NLR) — NLR captures the acute innate-vs-adaptive immune balance; a high NHR alongside a high NLR indicates both immune activation and HDL deficiency are contributing to cardiometabolic risk.
• HDL cholesterol — the denominator of the NHR; the standalone HDL-C level confirms whether a high NHR is denominator-driven (low HDL) or numerator-driven (neutrophilia), routing toward different clinical considerations.
• Absolute neutrophil count — isolates whether the ratio is being pulled up by true neutrophilia versus a denominator collapse, which changes the interpretation of the overall pattern.
• High-sensitivity CRP (hs-CRP) — the complementary hepatic inflammation signal; concordant elevation of hs-CRP and NHR provides a stronger systemic inflammation assessment than NHR alone.
• ApoB — links the lipid side of NHR to atherogenic particle count; high NHR plus high ApoB indicates both immune-inflammatory and particle-number risk are present simultaneously.

Pacing an NHR retest by the slower HDL component

The two components of NHR move on different timescales. Neutrophil counts can shift within hours to days in response to acute triggers — illness, heavy exercise, significant psychological stress, or a new medication. HDL cholesterol, by contrast, is a slower-moving denominator: meaningful changes in HDL-C typically require 8–12 weeks of sustained aerobic exercise or lipid-directed therapy before they are reliably detectable.

Because HDL sets the pace, the minimum practical retest window after a sustained lifestyle or therapeutic change is 8–12 weeks. Retesting sooner may capture neutrophil fluctuation without any corresponding HDL shift, producing a misleading picture of the ratio's trajectory.

For consistent comparisons across retests, standardize conditions: use a fasting lipid panel for the HDL draw, collect the CBC at the same time of day, and use the same laboratory and unit system each time. A single NHR value obtained during or shortly after illness, intense exercise, or acute stress is inherently noisy. Confirming a trend across two or three draws taken under stable conditions provides a far more reliable signal.

When an elevated NHR warrants a clinician's read

NHR is most useful as a trend marker rather than a one-time alarm. That said, certain patterns merit clinical attention. A persistently elevated NHR — confirmed across two or more stable draws — alongside concordant signals such as elevated hs-CRP, high ApoB, or a rising NLR suggests that both immune activation and lipid-mediated vascular risk may be operating together. This combination has been associated in research with arterial stiffness, insulin resistance, and oxidative stress, all of which are relevant to long-term cardiometabolic health.

An elevated NHR that does not respond to sustained lifestyle change over 12 or more weeks is also worth discussing with a clinician, as it may reflect an underlying metabolic or immune driver — such as undiagnosed metabolic syndrome, a chronic low-grade infection, or an autoimmune process — that warrants further investigation.

Two scenarios make NHR unreliable as a risk signal and should prompt caution in interpretation: if neutrophil count is artificially suppressed due to neutropenia from medication or a bone marrow disorder, the numerator no longer reflects immune activation; if HDL is at extreme highs due to genetic hyperalphalipoproteinemia, the denominator no longer reflects typical lipid-clearing capacity. In either case, the ratio should not be used in isolation.

Because NHR is derived from a standard CBC and lipid panel, tracking it over time adds interpretive depth at no additional testing cost. Superpower measures NHR alongside a broad panel of inflammation and lipid markers — including hs-CRP, ApoB, and NLR — turning isolated values into a coherent picture of immune-vascular balance. Learn more about the approach at our manifesto or visit superpower.com to get started.